In October 2011, the U.S. Justice Department announced that a biotech specialist at Cargill had pleaded guilty to stealing information from Cargill and Dow AgroSciences. Kexue Huang, a Chinese national, was discovered to be passing information back to China from Dow for at least 3 years, from 2007 to 2010.[6]
Dow AgroSciences unit was divested to be part of a new company Corteva.[7]
China
In 2014, Dow AgroSciences received the registration of Arylex's active ingredient (Halauxifen-methyl) from the Chinese Institute for the Control of Agrochemicals, Ministry of Agriculture (ICAMA).[1] In the United States, Dow AgoSciences' Enlist Weed Control System was approved by the Department of Agriculture (USDA) and the Environmental Protection Agency (EPA) in 2014.[2] Dow had submitted Enlist Corn for Chinese regulatory approval in 2011 and Enlist Soybean in 2012. As of 2017, even though 70 months have passed, approval is still being delayed by China's comparable regulatory agency, China's National Biosafety Committee (NBC). This has affected marketing, sales, and distribution of these products in the United States.[2]
^Thomas, David R. (May 17, 2011). "Evolution of Plant-Made Pharmaceuticals". International Journal of Molecular Sciences. 12 (5): 3220–3236. doi:10.3390/ijms12053220. PMC3116187. PMID21686181. (Section 3.2). On 31 January 2006, Dow AgroSciences LLC announced that it had received the world's first regulatory approval for a plant-made vaccine from the United States Department of Agriculture. The developed plant-made vaccine combats Newcastle Disease Virus